# US 8,715,706 B2 · Methods and devices for delivery of pharmaceutical agents within orifices of the body

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,715,706 B2
- Document ID: US8715706B2
- Status: Granted
- Kind: B2
- Application number: 13/379,022
- Filed: 2010-06-17
- Published: 2012-04-26
- Granted: 2014-05-06
- Earliest claimed: 2009-06-18
- Assignees: RDD Pharma Ltd.
- Applicants: Nir Barak
- Inventors: Nir Barak
- Web page: https://patentgrep.com/patent/US8715706B2

## CPC

- A61M 31/00: Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008})
- A61K 9/0031: {Rectum, anus}
- A61K 9/0036: {Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms}
- A61K 9/0046: {Ear}
- A61K 9/025: {characterised by shape or structure, e.g. hollow layered, coated}
- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A device for drug delivery to an orifice of a subject, comprising a shell which is elastically stressed by an active pharmaceutical ingredient, said shell containing and being substantially impermeable to said active pharmaceutical ingredient, wherein said shell has at least one hole sized for in-vivo release of said active pharmaceutical ingredient as a result of elastic stressing.

## Claims

### Claim 1

A drug release system comprising:
a drug delivery device comprising:
an elastic shell containing a pharmaceutical composition,
wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier and an active pharmaceutical ingredient, and
wherein the shell has an upper end, sides, and a lower portion with an aperture, the upper end and sides impermeable to the active pharmaceutical ingredient and impermeable to fluid; and
an elongated tail extending from the shell having at least one hole for releasing the active pharmaceutical agent,
wherein the elongated tail is impermeable to the active pharmaceutical ingredient and impermeable to fluid; and
a delivery element configured to deliver the shell into an orifice of a body, the delivery element comprising:
a housing having a distal end, a proximal end, and a longitudinal opening therebetween, wherein:
(i) the distal end of the housing is configured to engage the lower portion of the shell, and
(ii) the proximal end of the housing terminates in a radially extending first projection; and
a plunger having a distal end, a proximal end, and a longitudinal opening therebetween, wherein:
(i) the plunger is configured to house at least a portion of the elongated tail of the drug delivery device,
(ii) a diameter of the plunger is smaller than a diameter of the housing,
(iii) the distal end of the plunger sits within the proximal end of the housing,
(iv) the plunger is configured to move laterally within the housing, and
(v) the proximal end of the plunger terminates in a radially extending second projection.

### Claim 2 (depends on 1)

The drug release system of claim 1 wherein the distal end of the housing terminates in a radially extending third ring for controlling an amount of depth insertion of the shell in the orifice.

### Claim 3 (depends on 1)

The drug release system of claim 1 wherein an outer surface of the shell is provided with a lubricant layer.

### Claim 4 (depends on 1)

The drug release system of claim 1 wherein the lubricant layer comprises a local anesthetic.

### Claim 5 (depends on 1)

The drug release system of claim 1 wherein the shell is provided with a rounded tip.

### Claim 6 (depends on 1)

The drug release system of claim 1 wherein the shell is collapsible upon the release of the active pharmaceutical ingredient.

### Claim 7 (depends on 1)

The drug release system of claim 1 wherein the carrier further comprises at least one additional active pharmaceutical ingredient.

### Claim 8 (depends on 7)

The drug release system of claim 7 wherein the at least one additional active pharmaceutical ingredient is chosen from magnesium and salts thereof.

### Claim 9 (depends on 1)

The drug release system of claim 1 further comprising a release-controlling system within the shell for controlling delivery of the active pharmaceutical ingredient to at least one hole.

### Claim 10 (depends on 1)

The drug release system of claim 1 wherein at least one hole is realized as a plurality of holes.

### Claim 11 (depends on 10)

The drug release system of claim 10 wherein each hole of the plurality of holes is arranged in a predetermined pattern along the elongated tail.

### Claim 12 (depends on 1)

The drug release system of claim 1 wherein the elongated tail has a length of up to 10 cm as measured from the end of the shell.

### Claim 13 (depends on 12)

The drug release system of claim 12 wherein the carrier has a melting point in the range of from about 23° C. to about 37.5° C., such that the carrier becomes a liquid upon insertion of the shell into the orifice.

### Claim 14 (depends on 1)

The drug release system of claim 1 wherein the shell is sized for rectal insertion and the elongated tail has a length commensurate with a length of an anal canal.

### Claim 15 (depends on 1)

The drug release system of claim 1 wherein the active pharmaceutical ingredient is selected from the group consisting of a herbal extract, bee pollen, a muscle relaxant, a muscle constrictor, a local anesthetic, an antibiotic, an anti-inflammatory agent, a nitric oxide donor, botulinum toxin, a muscarinic agent, a sympathetic neuromodulator, a calcium channel antagonist, a phosphodiesterase inhibitor, a superoxide scavenger, a cyclic adenosine monophosphate-dependent protein kinase activator, a hormone, an antiepileptic agent, a sedative, a chemotherapeutic agent, anti-cancer medication, an analgesic, an adenosine triphosphate-sensitive calcium channel activator, or any mixtures thereof.

### Claim 16 (depends on 1)

The drug release system of claim 1 wherein the active pharmaceutical ingredient comprises Nifedipine.

### Claim 17 (depends on 1)

The drug release system of claim 1 wherein the shell is sized for vaginal insertion.

### Claim 18 (depends on 1)

The drug release system of claim 1 wherein the shell is sized for nasal insertion.

### Claim 19 (depends on 1)

The drug release system of claim 1 wherein the shell is sized for insertion in an ear.

### Claim 20 (depends on 1)

The drug release system of claim 1 wherein the elongated tail is sized to slow exiting of fluids therethrough such that exiting is over a period of hours.

### Claim 21 (depends on 1)

The drug release system of claim 1 wherein the shell can deform and squeeze the active pharmaceutical ingredient from the lower portion of the elongated tail.

### Claim 22 (depends on 1)

The drug release system of claim 1 wherein the carrier is polyethylene glycol.

### Claim 23 (depends on 1)

The drug release system of claim 1 wherein the shell is elastically stressed with the pharmaceutical composition so as to result in controlling a rate of release of the pharmaceutical composition.

### Claim 24 (depends on 1)

The drug release system of claim 1 wherein the elastic shell and the elongated tail are formed of a single material.

### Claim 25 (depends on 1)

The drug release system of claim 1 wherein the elastic shell and the elongated tail are formed together.

### Claim 26 (depends on 1)

The drug release system of claim 1 wherein the delivery element further comprises a clamp so as to allow for separation of the elastic shell from the plunger.
